Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors
Phosphoglycerate mutase 1 (PGAM1) coordinates glycolysis and biosynthesis to promote cancer cell proliferation, and is believed to be a promising target for cancer therapy. Herein, based on the anthraquinone scaffold, we synthesized 31 anthraquinone derivatives and investigated the structureW...
Main Authors: | Ke Huang, Lulu Jiang, Huiti Li, Deyong Ye, Lu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/5/845 |
Similar Items
-
The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors
by: Penghui Wang, et al.
Published: (2018-06-01) -
Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
by: Xiaoguang Li, et al.
Published: (2017-05-01) -
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion
by: Yao-An Wen, et al.
Published: (2018-01-01) -
Persistent Overexpression of Phosphoglycerate Mutase, a Glycolytic Enzyme, Modifies Energy Metabolism and Reduces Stress Resistance of Heart in Mice
by: Okuda, Junji
Published: (2014) -
Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
by: Wang Hai-Long, et al.
Published: (2016-01-01)